🇺🇸 FDA
Pipeline program

Esketamine

201450450

Unknown small_molecule completed

Quick answer

Esketamine for Postoperative Cognitive Dysfunction is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Postoperative Cognitive Dysfunction
Phase
Unknown
Modality
small_molecule
Status
completed

Clinical trials